Hi-Tech Pharmacal Co.’s (HITK) share price has entered into oversold territory with a stochastic value of 9.70. Analysts have been increasing their estimates on the company’s earnings for the year ending April 2010, sending the Zacks Consensus Estimate up 64 cents over the past 2 months to $2.06 per share. Hi-Tech Pharmacal is a Zacks #1 Rank (“Strong Buy”) company.
“HITK” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research